These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1252 related articles for article (PubMed ID: 7174325)
1. [Regional perfusion treatment in primary malignant melanomas of the extremities. (Microstage IV/V according to Clark and tumor thickness over 1.5 mm)]. Schraffordt Koops H; Oldhoff J Hautarzt; 1982 Sep; 33(9):506-10. PubMed ID: 7174325 [TBL] [Abstract][Full Text] [Related]
2. Local recurrence and survival in patients with (Clark Level IV/V and over 1.5-mm thickness) stage I malignant melanoma of the extremities after regional perfusion. Schraffordt Koops H; Beekhuis H; Oldhoff J; Oosterhuis JW; van der Ploeg E; Vermey A Cancer; 1981 Nov; 48(9):1952-7. PubMed ID: 7296506 [TBL] [Abstract][Full Text] [Related]
3. [Adjuvant regional isolation perfusion of the extremities of patients with stage I melanoma thicker than 1.5 mm]. Kroon BB; Schraffordt Koops H Ned Tijdschr Geneeskd; 1990 Oct; 134(42):2042-7. PubMed ID: 2234177 [TBL] [Abstract][Full Text] [Related]
4. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities. Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833 [TBL] [Abstract][Full Text] [Related]
5. Isolated regional perfusion in the treatment of malignant melanomas of the extremities. Schraffordt Koops H; Oldhoff J; van der Ploeg E; Vermey A; Eibergen R Arch Chir Neerl; 1975; 27(4):237-43. PubMed ID: 1211947 [TBL] [Abstract][Full Text] [Related]
6. [Hyperthermic regional perfusion in malignant melanoma of an extremity]. Andersson AP; Drzewiecki KT Ugeskr Laeger; 1992 Oct; 154(41):2815-9. PubMed ID: 1413222 [TBL] [Abstract][Full Text] [Related]
8. [Preventive lymph node excision in the treatment concept of melanoma of the extremities]. Binder J; Henneking K Zentralbl Chir; 1996; 121(6):474-7. PubMed ID: 8767334 [TBL] [Abstract][Full Text] [Related]
9. Limb recurrence-free interval and survival in patients with recurrent melanoma of the extremities treated with normothermic isolated perfusion. Klaase JM; Kroon BB; van Geel AN; van Wijk J; Franklin HR; Eggermont AM; Hart AA J Am Coll Surg; 1994 Jun; 178(6):564-72. PubMed ID: 8193749 [TBL] [Abstract][Full Text] [Related]
10. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone. Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986 [TBL] [Abstract][Full Text] [Related]
11. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345 [TBL] [Abstract][Full Text] [Related]